PosiFunda · Fundamentals

Kubota Pharmaceutical Holdings Co., Ltd.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Kubota Pharmaceutical Holdings Co., Ltd. made a loss over the last year. Kubota Pharmaceutical Holdings Co., Ltd. owes ¥0.10 for every ¥1 it owns. Kubota Pharmaceutical Holdings Co., Ltd. made a loss in each of the last two years.

Compared with Healthcare companies in Japan · latest annual results Dec 2025.

P/E ratio

Loss

Kubota Pharmaceutical Holdings Co., Ltd. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

5.87

The share price is 5.87 times Kubota Pharmaceutical Holdings Co., Ltd.'s book value per share, higher than 91% of Healthcare companies in Japan.

Market cap

¥9.4 B

The total market value of all of Kubota Pharmaceutical Holdings Co., Ltd.'s shares at today's price (share price × number of shares), smaller than 61% of Healthcare companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥1.6 B

What Kubota Pharmaceutical Holdings Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥9.88

Net worth divided by the number of shares. The share price of ¥58.00 is 5.9 times this, which is the P/B above.

Return on equity (ROE)

-65.2%

Kubota Pharmaceutical Holdings Co., Ltd. lost 65.2% of its shareholders' money over the last year, lower than 90% of Healthcare companies in Japan.

Owes vs Owns

0.10×

Kubota Pharmaceutical Holdings Co., Ltd. owes ¥0.10 for every ¥1 it owns (low), lower than 92% of Healthcare companies in Japan.

Dividend yield

None

Kubota Pharmaceutical Holdings Co., Ltd. does not currently pay a dividend.

Revenue growth

-22%

Revenue fell 22% in the year to Dec 2025, and grew 37% a year on average over 3 years.

Profit growth

Loss

Kubota Pharmaceutical Holdings Co., Ltd. made a loss in each of the last two years.

Profit margin

-3169.7%

Kubota Pharmaceutical Holdings Co., Ltd. lost ¥3170 for every ¥100 of revenue.

Interest cover

Not covered

Kubota Pharmaceutical Holdings Co., Ltd.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net cash

Kubota Pharmaceutical Holdings Co., Ltd. held ¥1.8 B more cash than debt (net cash) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Kubota Pharmaceutical Holdings Co., Ltd.: ¥9.4 B ÷ ¥1.6 B (30 Jun 2026) = 5.9.

What is Kubota Pharmaceutical Holdings Co., Ltd.'s return on equity?

Kubota Pharmaceutical Holdings Co., Ltd. lost 65.2% of its shareholders' money over the last year, lower than 90% of Healthcare companies in Japan.

How much does Kubota Pharmaceutical Holdings Co., Ltd. owe compared with what it owns?

Kubota Pharmaceutical Holdings Co., Ltd. owes ¥0.10 for every ¥1 it owns (low), lower than 92% of Healthcare companies in Japan.

Does Kubota Pharmaceutical Holdings Co., Ltd. pay a dividend?

No. Kubota Pharmaceutical Holdings Co., Ltd. does not currently pay a dividend.

Is Kubota Pharmaceutical Holdings Co., Ltd.'s revenue growing?

Revenue fell 22% in the year to Dec 2025, and grew 37% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.